Which aerosol therapy is used to open the airways in Cystic Fibrosis patients?

In the management of Cystic Fibrosis, bronchodilators are used to open the airways, making them the appropriate choice for facilitating airflow. Cystic Fibrosis leads to thick, sticky mucus accumulation in the airways, which can obstruct airflow and impair gas exchange. Bronchodilators function by relaxing the smooth muscles surrounding the airways, resulting in dilation and increased airflow, which helps alleviate symptoms such as wheezing and breathlessness.

While mucolytics can also play an important role in the treatment of Cystic Fibrosis, their primary function is to break down the thick mucus and assist in its clearance rather than directly relaxing the airways. Corticosteroids are primarily used for their anti-inflammatory properties, which can help reduce airway inflammation in certain conditions but are not primarily aimed at opening the airways. Antibiotics are essential for managing infections common in Cystic Fibrosis patients but do not address the airway obstruction caused by mucus accumulation.